Datamonitor Healthcare: data analysis and insight, Pink Shee...
Listen to the Pharma Intelligence podcasts on Spotify, Apple Podcasts, Soundcloud and Alexa
December 1 is World AIDS Day, dedicated to raising awareness of the worldwide AIDS pandemic caused by the spread of HIV infection. To commemorate the occasion, Informa Pharma Intelligence is offering a free download of the GlaxoSmithKline: Company Analysis report extract from Datamonitor Healthcare.
In it, PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27, which is highly dependent on successful uptake of two-drug regimens in HIV such as Juluca, cabotegravir/rilpivirine, and Tivicay/Epivir to drive growth.
The GlaxoSmithKline: Company Analysis extract contains vital information about GSK’s Q2 2018 review, including:
Datamonitor Healthcare: data analysis and insight
The World Health Organization defines mobile health (mHealth) as a “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices”. In the last decade, the health sector has seen a substantial rise in the number of mHealth apps, many of which are designed to assist users in weight reduction and diabetes management. In 2016, there were 79,000 apps available in the Health & Fitness category in the Google and Apple stores. However, the implementation of mHealth in oncology is lagging, and there are comparatively few available apps. There is a need for the development of more mHealth apps in oncology settings considering the increasing disease burden and potential clinical benefit.
Datamonitor Healthcare: data analysis and insight, Biomedtra...
Given the transformative nature of regenerative medicines, which can yield greatly improved patient responses, meet unmet need, and now exist as viable products on the market, cell and gene therapeutics developers over the past several years have been drawing deal attention, not only through collaborative partnerships, but also as acquisition targets.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: